Dysregulation of PAD4-mediated citrullination of nuclear GSK3β activates TGF-β signaling and induces epithelialto-mesenchymal transition in breast cancer cells

Sonja C. Stadler, C. Theresa Vincent, Victor D. Fedorov, Antonia Patsialou, Brian D. Cherrington, Joseph J. Wakshlag, Sunish Mohanan, Barry M. Zee, Xuesen Zhang, Benjamin A. Garcia, John S. Condeelis, Anthony M C Brown, Scott A. Coonrod, C. David Allis

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Peptidylarginine deiminase 4 (PAD4) is a Ca2+-dependent enzyme that converts arginine and methylarginine residues to citrulline, with histone proteins being among its best-described substrates to date. However, the biological function of this posttranslational modification, either in histones or in nonhistone proteins, is poorly understood. Here, we show that PAD4 recognizes, binds, and citrullinates glycogen synthase kinase-3β (GSK3β), both in vitro and in vivo. Among other functions, GSK3β is a key regulator of transcription factors involved in tumor progression, and its dysregulation has been associated with progression of human cancers. We demonstrate that silencing of PAD4 in breast cancer cells leads to a striking reduction of nuclear GSK3β protein levels, increased TGF-β signaling, induction of epithelial-to-mesenchymal transition, and production of more invasive tumors in xenograft assays. Moreover, in breast cancer patients, reduction of PAD4 and nuclear GSK3β is associated with increased tumor invasiveness. We propose that PAD4-mediated citrullination of GSK3β is a unique posttranslational modification that regulates its nuclear localization and thereby plays a critical role in maintaining an epithelial phenotype. We demonstrate a dynamic and previously unappreciated interplay between histone-modifying enzymes, citrullination of nonhistone proteins, and epithelial-to-mesenchymal transition.

Original languageEnglish (US)
Pages (from-to)11851-11856
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume110
Issue number29
DOIs
StatePublished - Jul 16 2013

Fingerprint

Glycogen Synthase Kinase 3
Breast Neoplasms
Histones
Epithelial-Mesenchymal Transition
Post Translational Protein Processing
Xenograft Model Antitumor Assays
Proteins
Neoplasms
Citrulline
Enzymes
Arginine
Transcription Factors
protein-arginine deiminase
Phenotype

ASJC Scopus subject areas

  • General

Cite this

Dysregulation of PAD4-mediated citrullination of nuclear GSK3β activates TGF-β signaling and induces epithelialto-mesenchymal transition in breast cancer cells. / Stadler, Sonja C.; Vincent, C. Theresa; Fedorov, Victor D.; Patsialou, Antonia; Cherrington, Brian D.; Wakshlag, Joseph J.; Mohanan, Sunish; Zee, Barry M.; Zhang, Xuesen; Garcia, Benjamin A.; Condeelis, John S.; Brown, Anthony M C; Coonrod, Scott A.; Allis, C. David.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 110, No. 29, 16.07.2013, p. 11851-11856.

Research output: Contribution to journalArticle

Stadler, SC, Vincent, CT, Fedorov, VD, Patsialou, A, Cherrington, BD, Wakshlag, JJ, Mohanan, S, Zee, BM, Zhang, X, Garcia, BA, Condeelis, JS, Brown, AMC, Coonrod, SA & Allis, CD 2013, 'Dysregulation of PAD4-mediated citrullination of nuclear GSK3β activates TGF-β signaling and induces epithelialto-mesenchymal transition in breast cancer cells', Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 29, pp. 11851-11856. https://doi.org/10.1073/pnas.1308362110
Stadler, Sonja C. ; Vincent, C. Theresa ; Fedorov, Victor D. ; Patsialou, Antonia ; Cherrington, Brian D. ; Wakshlag, Joseph J. ; Mohanan, Sunish ; Zee, Barry M. ; Zhang, Xuesen ; Garcia, Benjamin A. ; Condeelis, John S. ; Brown, Anthony M C ; Coonrod, Scott A. ; Allis, C. David. / Dysregulation of PAD4-mediated citrullination of nuclear GSK3β activates TGF-β signaling and induces epithelialto-mesenchymal transition in breast cancer cells. In: Proceedings of the National Academy of Sciences of the United States of America. 2013 ; Vol. 110, No. 29. pp. 11851-11856.
@article{28f64e7faf8144529d76f6a98d897612,
title = "Dysregulation of PAD4-mediated citrullination of nuclear GSK3β activates TGF-β signaling and induces epithelialto-mesenchymal transition in breast cancer cells",
abstract = "Peptidylarginine deiminase 4 (PAD4) is a Ca2+-dependent enzyme that converts arginine and methylarginine residues to citrulline, with histone proteins being among its best-described substrates to date. However, the biological function of this posttranslational modification, either in histones or in nonhistone proteins, is poorly understood. Here, we show that PAD4 recognizes, binds, and citrullinates glycogen synthase kinase-3β (GSK3β), both in vitro and in vivo. Among other functions, GSK3β is a key regulator of transcription factors involved in tumor progression, and its dysregulation has been associated with progression of human cancers. We demonstrate that silencing of PAD4 in breast cancer cells leads to a striking reduction of nuclear GSK3β protein levels, increased TGF-β signaling, induction of epithelial-to-mesenchymal transition, and production of more invasive tumors in xenograft assays. Moreover, in breast cancer patients, reduction of PAD4 and nuclear GSK3β is associated with increased tumor invasiveness. We propose that PAD4-mediated citrullination of GSK3β is a unique posttranslational modification that regulates its nuclear localization and thereby plays a critical role in maintaining an epithelial phenotype. We demonstrate a dynamic and previously unappreciated interplay between histone-modifying enzymes, citrullination of nonhistone proteins, and epithelial-to-mesenchymal transition.",
author = "Stadler, {Sonja C.} and Vincent, {C. Theresa} and Fedorov, {Victor D.} and Antonia Patsialou and Cherrington, {Brian D.} and Wakshlag, {Joseph J.} and Sunish Mohanan and Zee, {Barry M.} and Xuesen Zhang and Garcia, {Benjamin A.} and Condeelis, {John S.} and Brown, {Anthony M C} and Coonrod, {Scott A.} and Allis, {C. David}",
year = "2013",
month = "7",
day = "16",
doi = "10.1073/pnas.1308362110",
language = "English (US)",
volume = "110",
pages = "11851--11856",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "29",

}

TY - JOUR

T1 - Dysregulation of PAD4-mediated citrullination of nuclear GSK3β activates TGF-β signaling and induces epithelialto-mesenchymal transition in breast cancer cells

AU - Stadler, Sonja C.

AU - Vincent, C. Theresa

AU - Fedorov, Victor D.

AU - Patsialou, Antonia

AU - Cherrington, Brian D.

AU - Wakshlag, Joseph J.

AU - Mohanan, Sunish

AU - Zee, Barry M.

AU - Zhang, Xuesen

AU - Garcia, Benjamin A.

AU - Condeelis, John S.

AU - Brown, Anthony M C

AU - Coonrod, Scott A.

AU - Allis, C. David

PY - 2013/7/16

Y1 - 2013/7/16

N2 - Peptidylarginine deiminase 4 (PAD4) is a Ca2+-dependent enzyme that converts arginine and methylarginine residues to citrulline, with histone proteins being among its best-described substrates to date. However, the biological function of this posttranslational modification, either in histones or in nonhistone proteins, is poorly understood. Here, we show that PAD4 recognizes, binds, and citrullinates glycogen synthase kinase-3β (GSK3β), both in vitro and in vivo. Among other functions, GSK3β is a key regulator of transcription factors involved in tumor progression, and its dysregulation has been associated with progression of human cancers. We demonstrate that silencing of PAD4 in breast cancer cells leads to a striking reduction of nuclear GSK3β protein levels, increased TGF-β signaling, induction of epithelial-to-mesenchymal transition, and production of more invasive tumors in xenograft assays. Moreover, in breast cancer patients, reduction of PAD4 and nuclear GSK3β is associated with increased tumor invasiveness. We propose that PAD4-mediated citrullination of GSK3β is a unique posttranslational modification that regulates its nuclear localization and thereby plays a critical role in maintaining an epithelial phenotype. We demonstrate a dynamic and previously unappreciated interplay between histone-modifying enzymes, citrullination of nonhistone proteins, and epithelial-to-mesenchymal transition.

AB - Peptidylarginine deiminase 4 (PAD4) is a Ca2+-dependent enzyme that converts arginine and methylarginine residues to citrulline, with histone proteins being among its best-described substrates to date. However, the biological function of this posttranslational modification, either in histones or in nonhistone proteins, is poorly understood. Here, we show that PAD4 recognizes, binds, and citrullinates glycogen synthase kinase-3β (GSK3β), both in vitro and in vivo. Among other functions, GSK3β is a key regulator of transcription factors involved in tumor progression, and its dysregulation has been associated with progression of human cancers. We demonstrate that silencing of PAD4 in breast cancer cells leads to a striking reduction of nuclear GSK3β protein levels, increased TGF-β signaling, induction of epithelial-to-mesenchymal transition, and production of more invasive tumors in xenograft assays. Moreover, in breast cancer patients, reduction of PAD4 and nuclear GSK3β is associated with increased tumor invasiveness. We propose that PAD4-mediated citrullination of GSK3β is a unique posttranslational modification that regulates its nuclear localization and thereby plays a critical role in maintaining an epithelial phenotype. We demonstrate a dynamic and previously unappreciated interplay between histone-modifying enzymes, citrullination of nonhistone proteins, and epithelial-to-mesenchymal transition.

UR - http://www.scopus.com/inward/record.url?scp=84880361672&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880361672&partnerID=8YFLogxK

U2 - 10.1073/pnas.1308362110

DO - 10.1073/pnas.1308362110

M3 - Article

VL - 110

SP - 11851

EP - 11856

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 29

ER -